Anuradha Gupta is Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. Since joining Gavi in 2015, Anuradha has led efforts to put equity and gender at the centre of Gavi’s programmatic planning and to tailor support to countries within Gavi’s strategy. She has also driven efforts to create a new model of country-level Alliance support, through the establishment of the partners’ engagement framework (PEF). At the same time, Anuradha has helped to improve country ownership and leadership of Gavi-supported programmes while enhancing accountability for results. In 2019, Gavi received the prestigious Lasker~Bloomberg Public Service Award for providing sustained access to childhood vaccines in the world’s poorest countries, saving millions of lives and highlighting the power of immunisation to prevent diseases.
Prior to Gavi, Anuradha served as Mission Director of the National Health Mission of India, where she ran the largest – and possibly most complex – public health programme in the world with an annual budget of US$ 3.5 billion. A passionate and influential advocate of women, young girls and children, Anuradha played a leading role in India’s efforts to eradicate polio transmission, reduce maternal and child mortality and revitalise primary health care.
Anuradha has contributed towards a number of important global health initiatives. She served as a member of the Steering Committee for Child Survival Call to Action, co-chaired the Stakeholder Group for the 2012 London Summit on Family Planning and was a member of the Family Planning 2020 (FP2020) Reference Group. Anuradha served as Co-Chair of the Partnership for Maternal, Newborn & Child Health (PMNCH) and is currently a member of the PMNCH Board. She also played a role in shaping the Global Financing Facility (GFF) and is a member of the GFF Investors Group. From 2015-2018, Anuradha served on the Merck for Mothers Advisory Board.
Anuradha holds an MBA from the University of Wollongong in Australia and received executive education from the John F. Kennedy School of Government at Harvard University, Stanford Graduate School of Business and Maxwell School of Citizenship and Public Affairs at Syracuse University. In 2015, she was named one of “300 Women Leaders in Global Health” by the Global Health Centre of the Graduate Institute of International and Development Studies.
Opinion: COVID-19 threats facing women are daunting. We cannot be afraid of the challenge
Devex - Anuradha Gupta
Protecting Lower-Income Countries with COVID-19 Vaccines Requires Global Solidarity
UN Chronicle - Anuradha Gupta
Eliminating cervical cancer depends on global effort to ensure supply meets demand
World Economic Forum - Anuradha Gupta
India will play central role in equitable Covid-19 vaccine distribution across the world
The Economic Times - Anuradha Gupta